HCPBM [Heavy Charged Particles in Biology & Medicine] and ENLIGHT [European Network for Light Ions] Meetings, Oropa (Italy), June 2005

British Journal of Radiology

Volumn 79, Issue 940, 2006, Pages 278-284

  Jones, B ^a  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BEAM THERAPY; CANCER RADIOTHERAPY; CLINICAL STUDY; COMPUTER SYSTEM; COST BENEFIT ANALYSIS; ELECTRON; EUROPE; FINANCIAL MANAGEMENT; HADRON; HEALTH CARE ORGANIZATION; HODGKIN DISEASE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERNATIONAL COOPERATION; LINEAR ENERGY TRANSFER; MESON; NEUTRON; NEUTRON THERAPY; NOTE; OUTCOMES RESEARCH; PROSTATE CANCER; RADIATION DOSE DISTRIBUTION; RADIOBIOLOGY; RADIOSENSITIVITY; RECTUM CANCER; RELATIVE BIOLOGIC EFFECTIVENESS; SARCOMA; X RAY;

CLINICAL TRIALS; COSTS AND COST ANALYSIS; EUROPE; FAST NEUTRONS; FORECASTING; HUMANS; IONS; JAPAN; NEOPLASMS; PROTONS; RADIOBIOLOGY; RADIOTHERAPY, HIGH-ENERGY; RESEARCH DESIGN; UNITED STATES;

EID: 33645784571     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/23066263     Document Type: Note

References (18)

1. Suit H, Goldberg S, Niemerko A, Trofimov A, Adams J, et al. Proton beams to replace photon beams in radical dose treatments. Acta Oncologica 2003,42:800-8.
2. Jones B, Burnett NG. The future for radiotherapy: protons and ions hold much promise. Br Med J 2005;330:979-80.
3. Jones B, Rosenberg I. Particle Therapy Co-operative Oncology Group (PTCOG 40) Meeting Institute Curie 2004. Br J Radiol 2005;78:99-102.
4. Jones B. The case for particle therapy. Br J Radiol 2006;79: 24-31.
5. Errington RD, Ashby D, Gore SM, et al. High energy neutron treatment for pelvic cancers: study stopped because of increased mortality. Br Med J 1991;302:1045-51.
6. Maor MH, Errington RD, Caplan RJ, et al. Fast neutron therapy in advanced head & neck cancer: a collaborative international randomised trial. Int J Radiat Oncol Biol Phys 1995;32:99-604.
7. Schulz-Ertner D, Nikoghosyan A, Thilmann C, Haberer T, Jakel O, Karger C, et al. Results of carbon ion radiotherapy in 152 patients. Int J Radiat Oncol Biol Phys 2004;58:631-40.
8. Tsujii H, Mizoe J, Kamada T, Baba M, Kato S, Kato H, et al. Overview of clinical experiences on carbon ion radiotherapy at NIRS. Radiother Oncol 2004;73 (Suppl. 2):S41-9.
9. Debus J, Schulz-Ertner D, Schad L, Essig M, Rhein B, Thillmann CO, al. Stereotactic fractionated radiotherapy for chordomas and chondrosarcomas. Int J Radiat Oncol Biol Phys 2000;47:591-6.
10. Lomax AJ, Cella L, Weber D, Kurtz JM, Miralbell R. Potential role of intensity-modulated photons and protons in the treatment of the breast and regional nodes. Int J Radiat Oncol Biol Phys 2003;55:785-92.
11. Lomax AJ, Goitein M, Adams J. Intensity modulation in radiotherapy: photons versus protons in the paranasal sinus. Radiother Oncol 2003;66:11-8.
12. Prise KM, Schettino G, Folkard M, Held KD. New insights on cell death from radiation exposure. Lancet Oncol 2005;6:520-8.
13. Dale RG, Jones B. The assessment of RBE effects using the concept of Biologically Effective Dose. Int J Radiat Oncol Biol Phys 1998;43:639-45.
14. Jones B, Dale RG. Estimation of optimum dose per fraction for high LET radiations: implications for proton radiotherapy. Int J Radiat Oncol Biol Phys 2000;48:1549-57.
15. Schneider U, Zwahlen D, Ross D, Kaser-Hotz B. Estimation of radiation cancer from 3-D dose distributions: concept of organ equivalent dose. Int J Radiat Oncol Biol Phys 2005;61:1510-5.
16. Damato B, Lecuona K. Conservation of eyes with choroidal melanoma by a multimodality approach to treatment: an audit of 1632 patients. Opthalmology 2004;111:977-83.
17. Jones B. Science and Innovation Summit 2004. Br J Radiol 2005;78:17-9.
18. Jones B, Price P, Burnet NG, Roberts JT. Modelling the expected increase in demand for particle radiotherapy: implications for the UK. Br J Radiol 2005;78:832-5.